{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:56:26Z","timestamp":1787025386361,"version":"build-2736575974"},"reference-count":19,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic subdural hematoma (CSDH) is a condition that tends to recur frequently. Although middle meningeal artery embolization (MMAE) is an effective CSDH treatment, there is currently no consensus regarding the optimal timing for embolization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      In this single-center and retrospective study, we reviewed 72 cases with 1\n                      <jats:sup>st<\/jats:sup>\n                      -time recurrent CSDH from January 2018 to July 2023 and identified those treated with MMAE to examine its effect and the impact of differences in the timing of treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 72 cases with CSDH recurrence for the 1\n                      <jats:sup>st<\/jats:sup>\n                      time (mean age: 80.4 \u00b1 9.7 years; men: 62 [86.1%]; mean first recurrence interval: 33 \u00b1 24 days), 27 (37.5%) experienced a second recurrence. The mean first recurrence interval was shorter in cases with a second recurrence compared to cured cases: 24.3 \u00b1 18.6 versus 38.3 \u00b1 25.6 days, respectively (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.005). MMAE was performed in 17 (23.6%) cases (mean age: 82 \u00b1 6.2 years; men: 14 [82.4%]). The mean time from initial surgical treatment to embolization was 52.4 \u00b1 35.4 days, and the mean recurrence interval before MMAE was 24.9 \u00b1 19.6 days. Six cases (35.3%) experienced post-embolization recurrence and required surgical treatment. The mean recurrence interval before MMAE was shorter in cases with recurrence after MMAE (15 \u00b1 6.4 vs. 30 \u00b1 22.1 days,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.023). The time from initial surgical treatment to embolization was significantly shorter: 31.3 \u00b1 12.8 versus 63.9 \u00b1 38.9 days (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.039).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cases with a short first recurrence interval were more likely to experience a second recurrence. Repeated recurrences within a short time increased the likelihood of post-embolization recurrence. MMAE performed early following the initial surgical treatment increased the recurrence risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/sni_293_2024","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T04:05:20Z","timestamp":1718942720000},"page":"214","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Timing of chronic subdural hematoma treatment affects middle meningeal artery embolization outcome"],"prefix":"10.25259","volume":"15","author":[{"given":"Naoya","family":"Imai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Minokamo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Daiyukai General Hospital, Ichinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Toyohashi Medical Center, Toyohashi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Daiyukai General Hospital, Ichinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Aki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Daiyukai General Hospital, Ichinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Shirakami","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Daiyukai General Hospital, Ichinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"10.25259\/SNI_293_2024\/ref-1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/qjmed\/hcx143","article-title":"Increasing incidence of chronic subdural haematoma in the elderly","volume":"110","author":"Adhiyaman","year":"2017","journal-title":"QJM"},{"key":"10.25259\/SNI_293_2024\/ref-2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","article-title":"Pathophysiology of chronic subdural haematoma: Inflammation, angiogenesis and implications for pharmacotherapy","volume":"14","author":"Edlmann","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.25259\/SNI_293_2024\/ref-3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jnis-2022-019427","article-title":"Volumetric resolution of chronic subdural hematomas treated with surgical evacuation versus middle meningeal artery embolization during immediate, early, and late follow up: Propensity-score matched cohorts","volume":"15","author":"Housley","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"10.25259\/SNI_293_2024\/ref-4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/neurintsurg-2021-017352","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: A systematic review and meta-analysis","volume":"13","author":"Ironside","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"10.25259\/SNI_293_2024\/ref-5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5797\/jnet.oa.2018-0116","article-title":"Efficacy of middle meningeal artery embolization for organized chronic subdural hematoma","volume":"13","author":"Izawa","year":"2019","journal-title":"J Neuroendovasc Ther"},{"key":"10.25259\/SNI_293_2024\/ref-6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/neuros\/nyaa379","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: A multi-center experience of 154 consecutive embolizations","volume":"88","author":"Kan","year":"2021","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_293_2024\/ref-7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely-available easy-to-use software \u201cEZR\u201d (Easy R) for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.25259\/SNI_293_2024\/ref-8","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3171\/2022.9.JNS221663","article-title":"Middle meningeal artery embolization for treatment of chronic subdural hematomas: Does selection of embolized branches affect outcomes?","volume":"138","author":"Khorasanizadeh","year":"2022","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_293_2024\/ref-9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.wneu.2019.10.035","article-title":"Refractory chronic subdural hematoma associated with Dural metastasis of lung adenocarcinoma treated with endovascular embolization for the middle meningeal artery: A case report and review of the literature","volume":"133","author":"Kosaka","year":"2020","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_293_2024\/ref-10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/neuros\/nyy521","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: A series of 60 cases","volume":"85","author":"Link","year":"2019","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_293_2024\/ref-11","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.wneu.2019.08.175","article-title":"Time to and possible risk factors for recurrence after burr-hole drainage of chronic subdural hematoma: A subanalysis of the cSDH-drain randomized controlled trial","volume":"132","author":"Lutz","year":"2019","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_293_2024\/ref-12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jvir.2023.05.010","article-title":"Middle meningeal artery embolization with liquid embolic agents for chronic subdural hematoma: A systematic review and meta-analysis","volume":"34","author":"Mowla","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.25259\/SNI_293_2024\/ref-13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1227\/ons.0000000000000446","article-title":"Middle meningeal artery embolization for primary treatment of a chronic subdural hematoma in a pediatric patient: A systematic review of the literature and case report","volume":"24","author":"Paro","year":"2023","journal-title":"Oper Neurosurg"},{"key":"10.25259\/SNI_293_2024\/ref-14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10143-017-0860-x","article-title":"Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: A systematic review and meta-analysis","volume":"41","author":"Poon","year":"2018","journal-title":"Neurosurg Rev"},{"key":"10.25259\/SNI_293_2024\/ref-15","doi-asserted-by":"crossref","first-page":"e222045","DOI":"10.1148\/radiol.222045","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: Predictors of clinical and radiographic failure from 636 embolizations","volume":"307","author":"Salem","year":"2023","journal-title":"Radiology"},{"key":"10.25259\/SNI_293_2024\/ref-16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1227\/neu.0000000000002365","article-title":"Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: A systematic review and meta-analysis","volume":"92","author":"Sattari","year":"2023","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_293_2024\/ref-17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00011-012-0476-0","article-title":"Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: A prospective study","volume":"61","author":"Stanisic","year":"2012","journal-title":"Inflamm Res"},{"key":"10.25259\/SNI_293_2024\/ref-18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nec.2016.11.002","article-title":"Chronic subdural hematoma: Epidemiology and natural history","volume":"28","author":"Yang","year":"2017","journal-title":"Neurosurg Clin N Am"},{"key":"10.25259\/SNI_293_2024\/ref-19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/02688697.2020.1749987","article-title":"Chronic subdural haematoma in antithrombotic cohorts: Characteristics, surgical outcomes, and recurrence","volume":"34","author":"Zhang","year":"2020","journal-title":"Br J Neurosurg"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/timing-of-chronic-subdural-hematoma-treatment-affects-middle-meningeal-artery-embolization-outcome\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/timing-of-chronic-subdural-hematoma-treatment-affects-middle-meningeal-artery-embolization-outcome\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T05:09:45Z","timestamp":1732252185000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/timing-of-chronic-subdural-hematoma-treatment-affects-middle-meningeal-artery-embolization-outcome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":19,"alternative-id":["10.25259\/SNI_293_2024"],"URL":"https:\/\/doi.org\/10.25259\/sni_293_2024","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"article-number":"214"}}